Mentz, R. J., Buggey, J., Schulte, P. J., DeVore, A. D., Anstrom, K. J., Eisenstein, E. L., … Velazquez, E. J. (2014). Torsemide vs. Furosemide in Heart Failure Patients: Insights from Duke University Hospital. In Journal of Cardiac Failure (Vol. 20, pp. S95–S95). Elsevier BV. https://doi.org/10.1016/j.cardfail.2014.06.267

Mentz, Robert J., Jonathan Buggey, Phillip J. Schulte, Adam D. DeVore, Kevin J. Anstrom, Eric L. Eisenstein, Mona Fiuzat, Christopher M. O’Connor, and Eric J. Velazquez. “Torsemide vs. Furosemide in Heart Failure Patients: Insights from Duke University Hospital.” In Journal of Cardiac Failure, 20:S95–S95. Elsevier BV, 2014. https://doi.org/10.1016/j.cardfail.2014.06.267.

Mentz RJ, Buggey J, Schulte PJ, DeVore AD, Anstrom KJ, Eisenstein EL, et al. Torsemide vs. Furosemide in Heart Failure Patients: Insights from Duke University Hospital. In: Journal of Cardiac Failure. Elsevier BV; 2014. p. S95–S95.

Mentz, Robert J., et al. “Torsemide vs. Furosemide in Heart Failure Patients: Insights from Duke University Hospital.” Journal of Cardiac Failure, vol. 20, no. 8, Elsevier BV, 2014, pp. S95–S95. Crossref, doi:10.1016/j.cardfail.2014.06.267.

Mentz RJ, Buggey J, Schulte PJ, DeVore AD, Anstrom KJ, Eisenstein EL, Fiuzat M, O’Connor CM, Velazquez EJ. Torsemide vs. Furosemide in Heart Failure Patients: Insights from Duke University Hospital. Journal of Cardiac Failure. Elsevier BV; 2014. p. S95–S95.